Naringenin alleviates cisplatin induced muscle atrophy by regulating RIPK1/AMPK/NF-κB pathway

Naringenin alleviates cisplatin induced muscle atrophy by regulating RIPK1/AMPK/NF-κB pathway

Cisplatin (DDP) is a commonly used chemotherapy drug, but DDP can cause skeletal muscle atrophy and cachexia. This study combined the DDP-induced C2C12 myotube atrophy model and the LLC tumour-bearing mouse cachexia model under DDP treatment to explore the effect and mechanism of naringenin (NAR) in...

Full description

Bibliographic Details
Main Authors: Hong Zhang, Mengyi Chi, Yaxian Wang, Linlin Chen, Xipeng Sun, Lili Wan, Quanjun Yang, Cheng Guo
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Journal of Functional Foods
Subjects:
Naringenin
Cisplatin
Cachexia
Muscle atrophy
RIPK1/AMPK/NF-κB pathway
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464621003637

Internet

http://www.sciencedirect.com/science/article/pii/S1756464621003637

Similar Items